EXPERIMENTAL AND MOLECULAR PATHOLOGY

投稿咨询

官方网站：http://www.journals.elsevier.com/experimental-and-molecular-pathology/

投稿网址：https://www.evise.com/evise/faces/pages/login/login.jspx?resourceUrl=%2Ffaces%2Fpages%2Fnavigation%2FNavController.jspx%3FJRNL_ACR%3DEMP%26

PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0014-4800%5BISSN%5D

在新的编辑领导下，《实验与分子病理学》发表了关于疾病过程的原创文章，涉及哺乳动物组织和体液的结构和生化变化，以及分子生物学新技术在人类和其他动物病理学问题上的应用。该杂志还发表了一些由在当代病理学研究“前沿”工作的基层研究人员所作的精选的解释性综合评论。此外，特别主题的问题提出了原始的研究报告，解开了一些自然“最小心翼翼地守护着的秘密的病理基础上的疾病。研究领域包括:?干细胞?Neoangiogenesis?分子诊断?聚合酶链反应?原位杂交?DNA测序?细胞受体?致癌作用?肿瘤的病理生物学?复杂传染病?移植?细胞因子?流式细胞术分析?炎症?细胞损伤?免疫学和过敏?Athersclerosis好处的作者我们也提供许多作者的利益，如免费的pdf，自由的版权政策，特别折扣的爱思唯尔出版物和更多。请按此浏览更多有关作者服务的资料。有关文章提交的信息，请参阅我们的作者指南。

Under new editorial leadership, Experimental and Molecular Pathologypresents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems ofpathology in humans and other animals. The journal also publishes selected interpretive synthesis reviews by bench level investigators working at the "cutting edge" of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of Nature''''s most jealously guarded secrets on the pathologic basis of disease.Research Areas include:? Stem cells ? Neoangiogenesis ? Molecular diagnostics ? Polymerase chain reaction ? In situ hybridization ? DNA sequencing ? Cell receptors ? Carcinogenesis ? Pathobiology of neoplasia ? Complex infectious diseases ? Transplantation ? Cytokines ? Flow cytomeric analysis ? Inflammation ? Cellular injury ? Immunology and hypersensitivity ? AthersclerosisBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission.